BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 6287597)

  • 1. [Evaluation of a new antiemetic, alizapride, in cancerology (author's transl)].
    Cupissol D; Favier F; Favier C; Serrou B
    Sem Hop; 1982 Jun; 58(22):1370-3. PubMed ID: 6287597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antiemetic and antinauseant effect of alizapride in patients subjected to antiblastic infusion chemotherapy in a day-hospital regime].
    Cicchetti F; Viganò P; Borghi CM; Franzini A; Alfano G; Antolini C
    G Ital Oncol; 1989; 9(1):18-21. PubMed ID: 2707835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A double-blind study of alizapride in nausea and emesis induced by cancer chemotherapeutic agents (author's transl)].
    Viala JJ; Girard D; Cordier JF
    Sem Hop; 1982 Feb; 58(6):371-4. PubMed ID: 6280306
    [No Abstract]   [Full Text] [Related]  

  • 4. [Phase I study of alizapride in cancer patients treated with cisplatin].
    Nicaise C; Rozencweig M; Ortmans M; Frisque C; Bleiberg H
    Sem Hop; 1983 Sep; 59(31):2161-5. PubMed ID: 6312589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Alizapride in a double-blind trial with metoclopramide in nausea and vomiting caused by radiotherapy].
    Budach V; Krüger K
    Fortschr Med; 1983 Oct; 101(39):1792-4. PubMed ID: 6642386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [1 year's use of alizapride for the prevention and treatment of nausea and vomiting secondary to anticancer agents].
    Olivier JP
    Ann Gastroenterol Hepatol (Paris); 1985 Jan; 21(1):53-5. PubMed ID: 3977279
    [No Abstract]   [Full Text] [Related]  

  • 7. [Alizapride in the treatment of vomiting induced by cytostatic agents].
    Bierbaum HG
    Fortschr Med; 1983 Apr; 101(14):662-4. PubMed ID: 6852737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting. Results from a randomized, double-blind, placebo-controlled trial in Latin America.
    Poli-Bigelli S; Rodrigues-Pereira J; Carides AD; Julie Ma G; Eldridge K; Hipple A; Evans JK; Horgan KJ; Lawson F;
    Cancer; 2003 Jun; 97(12):3090-8. PubMed ID: 12784346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A study of the antiemetic effect of alizapride (author's transl)].
    Casanova P
    Sem Hop; 1982 Feb; 58(6):367-70. PubMed ID: 6280305
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiemetic effect of ondansetron and dexamethasone in gynecologic malignant patients receiving chemotherapy.
    Pradermdee P; Manusirivithaya S; Tangjitgamol S; Thavaramara T; Sukwattana P
    J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S29-36. PubMed ID: 17725140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Alizapride: a new antiemetic for severe vomiting during cancer polychemotherapy. Apropos of 20 cases].
    Toure P; Ndao D; Wandaogo A; Toure M
    Dakar Med; 1984; 29(2):339-42. PubMed ID: 6571252
    [No Abstract]   [Full Text] [Related]  

  • 12. [A study of alizapride, a new benzamide, in nausea and emesis in internal medicine (author's transl)].
    Girard D; Salles E; Bel A
    Sem Hop; 1982 Feb; 58(6):353-6. PubMed ID: 6280302
    [No Abstract]   [Full Text] [Related]  

  • 13. [A double-blind crossover trial of alizapride versus placebo regarding effectiveness against nausea and emesis induced by cancer chemotherapeutic agents (author's transl)].
    Pommatau E
    Sem Hop; 1982 Feb; 58(6):363-6. PubMed ID: 6280304
    [No Abstract]   [Full Text] [Related]  

  • 14. Alizapride, a new substituted benzamide, as an antiemetic during cancer chemotherapy.
    Joss RA; Galeazzi RL; Bischoff AK; Brunner KW
    Eur J Clin Pharmacol; 1985; 27(6):721-5. PubMed ID: 3987777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
    Sorbe BG
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal combination therapy with Navoban (tropisetron) in patients with incomplete control of chemotherapy-induced nausea and vomiting. The Belgian Navoban Group.
    Van Belle SJ; Cocquyt VF; Bleiberg H; Canon JL; Buyse M; Hulstaert F; De Witte M; De Keyser P; Westelinck K
    Anticancer Drugs; 1995 Feb; 6 Suppl 1():22-30. PubMed ID: 7749166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effectiveness of alizapride against emesis in infants and children (author's transl)].
    Carcassonne M
    Sem Hop; 1982 Feb; 58(6):357-61. PubMed ID: 6280303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of diazepam on delayed nausea and vomiting caused by anticancer agents].
    Tong FZ; Zhang JQ; Qiao XM; Mao YC; Meng FY; Liu HJ; Hui S; Zhu FX; Shu W; Hong J
    Gan To Kagaku Ryoho; 1998 Feb; 25(3):391-5. PubMed ID: 9492833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative double-blind study: alizapride-metoclopramide].
    Oberling F
    Ann Gastroenterol Hepatol (Paris); 1984; 20(1):59-61. PubMed ID: 6529162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug insight: New antiemetics in the management of chemotherapy-induced nausea and vomiting.
    Oo TH; Hesketh PJ
    Nat Clin Pract Oncol; 2005 Apr; 2(4):196-201. PubMed ID: 16264934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.